 CAMBRIDGE, Mass.--BUSINESS WIRE--Sage Therapeutics, Inc. NASDAQ: SAGE, a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, announced today that the Company will present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022 at 7:30am ET. A live webcast of the presentation can be accessed on the Investor page of Sages website at investor.sagerx.com. A repl 